ROTAVIRUS VACCINE ASPEN

Indications

• Measles
• Mumps
• Rubella
• Yellow fever
• Varicella (chickenpox)
• Rotavirus

Dosage

Children: Refer to specific vaccine guidelines for paediatric dosing.

Adults: Refer to specific vaccine guidelines for adult dosing.

Mechanism of action

Attenuated vaccines work by mimicking a natural infection. The weakened pathogen replicates in the body, stimulating the immune system to produce a response against it, which includes the activation of T-cells and the production of antibodies. This prepares the immune system to recognize and fight off the pathogen if exposed in the future.

Pharmacodynamics

The pharmacodynamics of attenuated vaccines involve the interaction of the attenuated pathogen with the host's immune system. Upon administration, the vaccine induces both humoral (antibody-mediated) and cell-mediated immunity. This leads to the development of memory cells that ensure a faster and more effective response upon subsequent exposure to the actual pathogen.

Pharmacokinetics

Attenuated vaccines are generally administered via subcutaneous or intramuscular injection. The pharmacokinetics are characterized by the distribution of the vaccine components within the body, with the attenuated organisms replicating locally and inducing an immune response. The onset of immunity typically occurs within weeks, and the duration of immunity can vary depending on the specific vaccine.

Contra-indications

• Severe immunodeficiency
• Pregnant women (specific live attenuated vaccines)
• Severe allergic reactions to vaccine components

Adverse effects

• Injection site reactions (pain, swelling, redness)
• Low-grade fever
• Malaise
• Rash
• Rare neurological complications (e.g., Guillain-Barré syndrome)

Interactions

• Immunosuppressive agents (may reduce vaccine efficacy)
• Blood products (may interfere with immune response to vaccine)
• Other live vaccines (timing may affect immune response)

Precautions

• History of allergic reactions to previous vaccinations
• Presence of active infections
• Chronic illnesses that may affect immune response

Pregnancy

Live attenuated vaccines are generally contraindicated during pregnancy due to potential risks to the fetus.

Breast-feeding

Most live attenuated vaccines are considered safe during breastfeeding, but caution and consultation with a healthcare provider are advised.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Injectable suspension
• Oral suspension
• Lyophilized powder for reconstitution

Indications

• Diabetes mellitus
• Hypoglycemia
• Certain immunodeficiencies
• Replacement therapy for hormone deficiencies

Dosage

Children: Refer to the specific product guidelines for dosing, as it varies widely based on the type of bovine-derived treatment.

Adults: Refer to the specific product guidelines for dosing, as it varies widely based on the type of bovine-derived treatment.

Mechanism of action

Bovine-derived products, such as insulin from bovine pancreas, function by mimicking the action of human hormones or proteins in the body. For example, insulin facilitates glucose uptake by cells, thereby lowering blood glucose levels in diabetic patients. The mechanism of action is largely dependent on the specific bovine product in question.

Pharmacodynamics

The pharmacodynamics vary widely depending on the specific bovine product. For insulin, the pharmacodynamics involve promoting the transport of glucose into cells, inhibiting hepatic glucose production, and enhancing lipid storage. Other bovine-derived products may have different effects based on their biological functions.

Pharmacokinetics

Pharmacokinetics also depend on the specific bovine product. For bovine insulin, absorption occurs rapidly after subcutaneous administration, with a peak effect typically seen within a few hours. The half-life can vary; for example, regular insulin has a short half-life, while long-acting formulations can provide sustained effects. Distribution and elimination will also depend on the specific product and formulation.

Pregnancy

There is limited data on the use of bovine-derived products during pregnancy. Caution is advised.

Breast-feeding

Limited data available; consult healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Specific storage conditions may vary based on the formulation.

Dosage

Children: Dosage for human-derived biological products in pediatrics should be determined based on specific product guidelines and the clinical context.

Adults: Dosage for human-derived biological products varies widely. Refer to specific product information for appropriate dosing.

Mechanism of action

Human physiology is governed by complex biological systems involving various cellular and molecular pathways. The mechanisms of action for human-derived biological products vary widely depending on the specific context, including immune response, hormonal regulation, and metabolic processes.

Pharmacodynamics

Pharmacodynamics in humans involves the interaction of drugs with biological systems, resulting in therapeutic effects. This includes receptor binding, signal transduction, and physiological responses. The effects are influenced by genetic factors, existing health conditions, and concurrent medications.

Pharmacokinetics

Pharmacokinetics in humans involves the absorption, distribution, metabolism, and excretion (ADME) of substances. Factors such as age, sex, body weight, and organ function can significantly influence these processes. Drug absorption may occur via oral, intravenous, or other routes, while distribution depends on blood flow and tissue permeability. Metabolism typically occurs in the liver, and excretion primarily takes place through the kidneys.

Pregnancy

There is no specific information available; consult local guidelines.

Breast-feeding

There is no specific information available; consult local guidelines.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Indications

• Influenza prevention
• Viral respiratory infections
• Pediatric vaccination programs

Dosage

Children: Refer to specific guidelines based on the type of reassortant vaccine used, as dosing can vary.

Adults: Refer to specific guidelines based on the type of reassortant vaccine used, as dosing can vary.

Mechanism of action

Reassortant viruses work by introducing specific genes from a virulent strain into a backbone of a less virulent or attenuated strain. When administered, the vaccine stimulates the immune system to recognize and respond to the surface antigens of the virus, particularly hemagglutinin and neuraminidase, leading to the production of neutralizing antibodies. This prepares the immune system to respond more effectively to natural infections by the wild-type virus.

Pharmacodynamics

The pharmacodynamics of reassortant vaccines involve the interaction between the vaccine and the immune system, leading to the activation of both humoral and cellular immunity. Following vaccination, the body produces specific antibodies against the reassorted viral antigens, enhancing the immunological memory. This results in a quicker and more robust immune response upon subsequent exposure to the actual virus, reducing the severity and duration of the disease.

Pharmacokinetics

Reassortant vaccines are typically administered via intramuscular or subcutaneous injection. After administration, the vaccine components are processed by antigen-presenting cells, leading to T-cell activation and subsequent antibody production. The onset of immunity usually occurs within a few weeks, with the duration of protective immunity varying based on the specific vaccine and population factors. Clearance of the vaccine components is primarily through normal metabolic pathways, with no specific half-life defined due to the nature of vaccines.

Pregnancy

The safety of reassortant vaccines during pregnancy is not fully established. Pregnant individuals should consult healthcare providers before vaccination.

Breast-feeding

Reassortant vaccines are generally considered safe during breastfeeding, but it is advisable to consult a healthcare professional.

Storage

Reassortant vaccines should be stored in a refrigerator at 2-8 degrees Celsius, protected from light. Do not freeze.

Indications

• Rotavirus gastroenteritis
• Prevention of rotavirus-related diarrhea in infants and children

Dosage

Children: Refer to the BNF for Children for specific vaccination schedules and dosing information related to rotavirus vaccination.

Mechanism of action

Rotavirus infects and replicates in the epithelial cells of the small intestine. The virus disrupts the normal function of these cells, leading to malabsorption of nutrients and water. The infection triggers an inflammatory response, resulting in increased intestinal permeability, secretion of electrolytes and water into the intestinal lumen, and subsequent diarrhea.

Pharmacodynamics

The body's immune response plays a crucial role in controlling rotavirus infections. The production of antibodies against rotavirus is stimulated by natural infection and vaccination. These antibodies help neutralize the virus and prevent future infections. The severity of the disease is often related to the host's immune status and the age of the child at the time of infection.

Pharmacokinetics

As a virus, rotavirus does not follow traditional pharmacokinetic profiles like absorption, distribution, metabolism, and excretion seen with drugs. Instead, the focus is on the replication cycle of the virus within the host's intestinal cells and the resultant immune response. The stability of rotavirus outside the host is significant for transmission, as it can survive on surfaces for long periods.

Contra-indications

• Severe allergic reaction to any component of the vaccine
• History of intussusception
• Severe combined immunodeficiency (SCID)
• Moderate or severe acute illness

Adverse effects

• Diarrhea
• Vomiting
• Fever
• Irritability
• Intussusception (rarely)
• Allergic reactions (rare)

Interactions

• Immunosuppressive therapies may reduce vaccine efficacy
• Other live vaccines should generally be given at the same visit or separated by at least 4 weeks

Precautions

• Monitor for signs of intussusception after vaccination
• Use with caution in individuals with a history of gastrointestinal disorders
• Pregnant women should not receive the vaccine

Pregnancy

The vaccine is not recommended during pregnancy due to lack of safety data.

Breast-feeding

Safe to use during breastfeeding; no contraindications.

Storage

Store in a refrigerator (2°C to 8°C). Do not freeze.

Formulations

• Oral suspension for vaccination